Valirx Plc (VAL.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 06-2025 | 12-2024 | 06-2024 | 12-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 519 | 1,556 | 809 | 175 | 891 |
| Inventories | 69 | 69 | 69 | 69 | N/A |
| Other current assets | 257 | 272 | 327 | 323 | 484 |
| TOTAL | $845 | $1,897 | $1,205 | $566 | $1,375 |
| Non-Current Assets | |||||
| PPE Net | 170 | 202 | 232 | 243 | 276 |
| Intangibles | 2,055 | 2,133 | 2,226 | 2,321 | 2,421 |
| Other Non-Current Assets | 30 | 30 | 30 | 0 | 0 |
| TOTAL | $2,254 | $2,365 | $2,488 | $2,564 | $2,697 |
| Total Assets | $3,099 | $4,262 | $3,692 | $3,130 | $4,072 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 7 | 10 | 10 | 10 | 10 |
| Accounts payable and accrued liabilities | 81 | 148 | 171 | 125 | 91 |
| TOTAL | $87 | $345 | $181 | $215 | $103 |
| Non-Current Liabilities | |||||
| Long Term Debt | 0 | 1 | 7 | 12 | 17 |
| Other Non-Current Liabilities | 440 | 402 | 343 | 315 | 251 |
| TOTAL | $0 | $1 | $7 | $12 | $17 |
| Total Liabilities | $87 | $346 | $188 | $227 | $120 |
| Shareholders' Equity | |||||
| Common Shares | 9,979 | 374 | 9,737 | 102 | 9,707 |
| Retained earnings | -39,312 | -38,492 | -37,652 | -36,681 | -35,679 |
| Other shareholders' equity | 2,198 | 11,822 | 2,341 | 11,927 | 2,303 |
| TOTAL | $3,452 | $4,317 | $3,848 | $3,219 | $4,204 |
| Total Liabilities And Equity | $3,539 | $4,664 | $4,036 | $3,445 | $4,324 |